Fixed-dose combination of alogliptin/pioglitazone improves glycemic control in Japanese patients with type 2 diabetes mellitus independent of body mass index

por Aoki, Chie, Suzuki, Kunihiro, Kuroda, Hisamoto, Sagara, Masaaki, Shimizu, Masanori, Kasai, Kikuo, Aso, Yoshimasa
Publicado 2017

Evaluation of a Premixed Insulin Analog Suspension in Japanese People with Type 2 Diabetes and the Clinical Importance of Improved Injection Techniques: A Cross-Sectional Pilot Stu...

por Suzuki, Kunihiro, Aoki, Chie, Kato, Kanako, Shimizu, Masanori, Sakurai, Shintaro, Yanagi, Kazunori, Kuroda, Hisamoto, Aso, Yoshimasa
Publicado 2017

Dapagliflozin improves treatment satisfaction in overweight patients with type 2 diabetes mellitus: a patient reported outcome study (PRO study)

por Nakajima, Hiroki, Okada, Sadanori, Mohri, Takako, Kanda, Eiichiro, Inaba, Naoyuki, Hirasawa, Yoko, Seino, Hiroaki, Kuroda, Hisamoto, Hiyoshi, Toru, Niiya, Tetsuji, Ishii, Hitoshi
Publicado 2018

Rationale and Design of the STOP-OB Study for Evaluating the Effects of Tofogliflozin and Glimepiride on Fat Deposition in Type 2 Diabetes Patients Treated with Metformin/DPP-4 Inh...

por Ishihara, Hisamitsu, Anai, Motonobu, Seino, Hiroaki, Kitazawa, Toru, Ohashi, Hiroshi, Ai, Masumi, Inoue, Masahiro, Fujishiro, Midori, Inazawa, Takeshi, Kuroda, Hisamoto, Yamada, Masayo
Publicado 2018

Comparison of tofogliflozin versus glimepiride as the third oral agent added to metformin plus a dipeptidyl peptidase‐4 inhibitor in Japanese patients with type 2 diabetes: A rando...

por Kitazawa, Toru, Seino, Hiroaki, Ohashi, Hiroshi, Inazawa, Takeshi, Inoue, Masahiro, Ai, Masumi, Fujishiro, Midori, Kuroda, Hisamoto, Yamada, Masayo, Anai, Motonobu, Ishihara, Hisamitsu
Publicado 2020